Duodenal Perforation As Presentation of Gastric Neuroendocrine Tumour: A Case Report

Overview

Journal Int J Surg Case Rep

Specialty General Surgery

Date 2020 Sep 28

PMID 32981880

Authors

Giuseppe Di Buono

Giulia Bonventre

Giuseppe Badalamenti

Salvatore Buscemi

Giorgio Romano

Antonino Agrusa

Affiliations

Soon will be listed here.

Abstract

Introduction: Neuroendocrine tumors (NETs) represent uncommon neoplasms with different characteristics. They can be asymptomatic and benign or they can also proliferate and manifest themselves with neoplastic mass symptoms such as intestinal occlusion or with carcinoid syndrome. Gastric neuroendocrine neoplasms (g-NENs) are the most frequent digestive NENs while duodenal neuroendocrine neoplasms (d-NENs) may be sporadic or associated with multiple endocrine neoplasia type 1 (MEN-1) and present a functional syndrome (e.g. gastrinoma with Zollinger-Ellison syndrome).

Presentation Of Case: We report a case of duodenal perforation due to a unknown gastrinoma responsible of Zollinger-Ellison Syndrome. He underwent an emergency contrast enhanced CT abdominal scan that showed a perforation. We performed a distal gastrectomy. The histopathological examination revealed a g-NET configuring a possible picture of Zollinger-Ellison Syndrome.

Discussion: The management of NETs is diffulcult and controversial because of their rarity. It is useful to know the pathologic assessment of tumor differentiation and/or grade, evaluate surgical resectability and control the carcinoid syndrome symptoms.

Conclusion: This case report shows that gastric NETs can be found in cases of duodenal perforation. Our future goal is to evaluate the possibilities to diagnose the Zollinger Ellison Syndrome as early as possible and to treat it with targeted therapy in order to prevent its related complications.

References

Thomaschewski M, Neeff H, Keck T, Neumann H, Strate T, von Dobschuetz E . Is there any role for minimally invasive surgery in NET?. Rev Endocr Metab Disord. 2017; 18(4):443-457. DOI: 10.1007/s11154-017-9436-x. View

Agha R, Fowler A, Saeta A, Barai I, Rajmohan S, Orgill D . The SCARE Statement: Consensus-based surgical case report guidelines. Int J Surg. 2016; 34:180-186. DOI: 10.1016/j.ijsu.2016.08.014. View

Gibril F, Jensen R . Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome. Curr Gastroenterol Rep. 2005; 7(2):114-21. DOI: 10.1007/s11894-005-0049-2. View

Galia M, Albano D, Bruno A, Agrusa A, Romano G, Di Buono G . Imaging features of solid renal masses. Br J Radiol. 2017; 90(1077):20170077. PMC: 5858810. DOI: 10.1259/bjr.20170077. View

Anderson B, Sweetser S . Gastrointestinal: Zollinger-Ellison Syndrome: A rare cause of chronic diarrhea and abdominal pain. J Gastroenterol Hepatol. 2017; 32(7):1281. DOI: 10.1111/jgh.13630. View

Agrusa A, Frazzetta G, Chianetta D, Di Giovanni S, Gulotta L, Di Buno G . "Relaparoscopic" management of surgical complications: The experience of an Emergency Center. Surg Endosc. 2015; 30(7):2804-10. DOI: 10.1007/s00464-015-4558-2. View

Strosberg J, Halfdanarson T, Bellizzi A, Chan J, Dillon J, Heaney A . The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 2017; 46(6):707-714. PMC: 5642985. DOI: 10.1097/MPA.0000000000000850. View

Scherubl H, Cadiot G, Jensen R, Rosch T, Stolzel U, Kloppel G . Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?. Endoscopy. 2010; 42(8):664-71. DOI: 10.1055/s-0030-1255564. View

Galia M, Albano D, Picone D, Terranova M, Agrusa A, Di Buono G . Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma. Clin Imaging. 2018; 51:76-82. DOI: 10.1016/j.clinimag.2018.01.016. View

10.

Norton J, Fraker D, Alexander H, Jensen R . Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg. 2012; 256(3):509-17. PMC: 3477644. DOI: 10.1097/SLA.0b013e318265f08d. View

11.

Falconi M, Eriksson B, Kaltsas G, Bartsch D, Capdevila J, Caplin M . ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016; 103(2):153-71. PMC: 4849884. DOI: 10.1159/000443171. View

12.

Oronsky B, Ma P, Morgensztern D, Carter C . Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia. 2017; 19(12):991-1002. PMC: 5678742. DOI: 10.1016/j.neo.2017.09.002. View

13.

Romano G, Agrusa A, Galia M, Di Buono G, Chianetta D, Sorce V . Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center. Int J Surg. 2015; 21 Suppl 1:S68-71. DOI: 10.1016/j.ijsu.2015.06.062. View

14.

Agha R, Borrelli M, Farwana R, Koshy K, Fowler A, Orgill D . The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2018; 60:132-136. DOI: 10.1016/j.ijsu.2018.10.028. View

15.

Agrusa A, Romano G, Navarra G, Conzo G, Pantuso G, Di Buono G . Innovation in endocrine surgery: robotic versus laparoscopic adrenalectomy. Meta-analysis and systematic literature review. Oncotarget. 2017; 8(60):102392-102400. PMC: 5731964. DOI: 10.18632/oncotarget.22059. View

16.

Albano D, Agnello F, Midiri F, Pecoraro G, Bruno A, Alongi P . Imaging features of adrenal masses. Insights Imaging. 2019; 10(1):1. PMC: 6349247. DOI: 10.1186/s13244-019-0688-8. View

17.

Agrusa A, Di Buono G, Buscemi S, Cucinella G, Romano G, Gulotta G . 3D laparoscopic surgery: a prospective clinical trial. Oncotarget. 2018; 9(25):17325-17333. PMC: 5915119. DOI: 10.18632/oncotarget.24669. View

18.

Yu F, Venzon D, Serrano J, Goebel S, Doppman J, Gibril F . Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol. 1999; 17(2):615-30. DOI: 10.1200/JCO.1999.17.2.615. View